Works matching AU Pratley, Richard E.

Results: 210
    1
    2

    Supporting the 'lived expertise' of older adults with type 1 diabetes: An applied focus group analysis to characterize barriers, facilitators, and strategies for self‐management in a growing and understudied population.

    Published in:
    Diabetic Medicine, 2024, v. 41, n. 1, p. 1, doi. 10.1111/dme.15156
    By:
    • Cristello Sarteau, Angelica;
    • Muthukkumar, Rashmi;
    • Smith, Cambray;
    • Busby‐Whitehead, Jan;
    • Lich, Kristen Hassmiller;
    • Pratley, Richard E.;
    • Thambuluru, Sirisha;
    • Weinstein, Joshua;
    • Weinstock, Ruth S.;
    • Young, Laura A.;
    • Kahkoska, Anna R.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality.

    Published in:
    Diabetologia, 2018, v. 61, n. 1, p. 58, doi. 10.1007/s00125-017-4422-0
    By:
    • Pieber, Thomas R.;
    • Marso, Steven P.;
    • McGuire, Darren K.;
    • Zinman, Bernard;
    • Poulter, Neil R.;
    • Emerson, Scott S.;
    • Pratley, Richard E.;
    • Woo, Vincent;
    • Heller, Simon;
    • Lange, Martin;
    • Brown-Frandsen, Kirstine;
    • Moses, Alan;
    • Barner Lekdorf, Jesper;
    • Lehmann, Lucine;
    • Kvist, Kajsa;
    • Buse, John B.;
    • on behalf of the DEVOTE Study Group
    Publication type:
    Article
    9

    Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).

    Published in:
    Diabetologia, 2018, v. 61, n. 1, p. 48, doi. 10.1007/s00125-017-4423-z
    By:
    • Zinman, Bernard;
    • Marso, Steven P.;
    • Poulter, Neil R.;
    • Emerson, Scott S.;
    • Pieber, Thomas R.;
    • Pratley, Richard E.;
    • Lange, Martin;
    • Brown-Frandsen, Kirstine;
    • Moses, Alan;
    • Ocampo Francisco, Ann Marie;
    • Barner Lekdorf, Jesper;
    • Kvist, Kajsa;
    • Buse, John B.;
    • on behalf of the DEVOTE Study Group
    Publication type:
    Article
    10
    11
    12
    13
    14

    Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1398, doi. 10.1111/dom.14965
    By:
    • Kim, Joseph M.;
    • Bhatt, Deepak L.;
    • Dagogo‐Jack, Samuel;
    • Cherney, David Z. I.;
    • Cosentino, Francesco;
    • McGuire, Darren K.;
    • Pratley, Richard E.;
    • Liu, Chih‐Chin;
    • Cater, Nilo B.;
    • Frederich, Robert;
    • Mancuso, James P.;
    • Cannon, Christopher P.
    Publication type:
    Article
    15
    16

    Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium‐glucose cotransporter‐2 inhibitor ertugliflozin

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 758, doi. 10.1111/dom.14923
    By:
    • Corbin, Karen D.;
    • Dagogo‐Jack, Samuel;
    • Cannon, Christopher P.;
    • Cherney, David Z.I.;
    • Cosentino, Francesco;
    • Frederich, Robert;
    • Liu, Jie;
    • Pong, Annpey;
    • Lin, Jianxin;
    • Cater, Nilo B.;
    • Pratley, Richard E.
    Publication type:
    Article
    17

    Weight management in young adults with type 1 diabetes: The advancing care for type 1 diabetes and obesity network sequential multiple assignment randomized trial pilot results.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 688, doi. 10.1111/dom.14911
    By:
    • Igudesman, Daria;
    • Crandell, Jamie;
    • Corbin, Karen D.;
    • Zaharieva, Dessi P.;
    • Addala, Ananta;
    • Thomas, Joan M.;
    • Casu, Anna;
    • Kirkman, M. Sue;
    • Pokaprakarn, Teeranan;
    • Riddell, Michael C.;
    • Burger, Kyle;
    • Pratley, Richard E.;
    • Kosorok, Michael R.;
    • Maahs, David M.;
    • Mayer‐Davis, Elizabeth J.
    Publication type:
    Article
    18

    Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1829, doi. 10.1111/dom.14769
    By:
    • Segar, Matthew W.;
    • Kolkailah, Ahmed A.;
    • Frederich, Robert;
    • Pong, Annpey;
    • Cannon, Christopher P.;
    • Cosentino, Francesco;
    • Dagogo‐Jack, Samuel;
    • McGuire, Darren K.;
    • Pratley, Richard E.;
    • Liu, Chih‐Chin;
    • Maldonado, Mario;
    • Liu, Jie;
    • Cater, Nilo B.;
    • Pandey, Ambarish;
    • Cherney, David Z. I.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 569, doi. 10.1111/dom.14254
    By:
    • Espeland, Mark A.;
    • Pratley, Richard E.;
    • Rosenstock, Julio;
    • Kadowaki, Takashi;
    • Seino, Yutaka;
    • Zinman, Bernard;
    • Marx, Nikolaus;
    • McGuire, Darren K.;
    • Andersen, Knut Robert;
    • Mattheus, Michaela;
    • Keller, Annett;
    • Weber, Maria;
    • Johansen, Odd Erik
    Publication type:
    Article
    25
    26

    Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2487, doi. 10.1111/dom.14160
    By:
    • Verma, Subodh;
    • McGuire, Darren K.;
    • Bain, Stephen C.;
    • Bhatt, Deepak L.;
    • Leiter, Lawrence A.;
    • Mazer, C. David;
    • Monk Fries, Tea;
    • Pratley, Richard E.;
    • Rasmussen, Søren;
    • Vrazic, Hrvoje;
    • Zinman, Bernard;
    • Buse, John B.
    Publication type:
    Article
    27

    Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2241, doi. 10.1111/dom.14049
    By:
    • Heller, Simon;
    • Lingvay, Ildiko;
    • Marso, Steven P.;
    • Philis‐Tsimikas, Athena;
    • Pieber, Thomas R.;
    • Poulter, Neil R.;
    • Pratley, Richard E.;
    • Hachmann‐Nielsen, Elise;
    • Kvist, Kajsa;
    • Lange, Martin;
    • Moses, Alan C.;
    • Andresen, Marie Trock;
    • Buse, John B.
    Publication type:
    Article
    28
    29
    30

    The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1690, doi. 10.1111/dom.14079
    By:
    • Leiter, Lawrence A.;
    • Bain, Stephen C.;
    • Bhatt, Deepak L.;
    • Buse, John B.;
    • Mazer, C. David;
    • Pratley, Richard E.;
    • Rasmussen, Søren;
    • Ripa, Maria Sejersten;
    • Vrazic, Hrvoje;
    • Verma, Subodh
    Publication type:
    Article
    31
    32
    33
    34
    35

    Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7).

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1625, doi. 10.1111/dom.13699
    By:
    • Pratley, Richard E.;
    • Buse, John B.;
    • Emerson, Scott S.;
    • Franek, Edward;
    • Gilbert, Matthew P.;
    • Marso, Steven P.;
    • McGuire, Darren K.;
    • Pieber, Thomas R.;
    • Zinman, Bernard;
    • Hansen, Charlotte T.;
    • Hansen, Melissa V.;
    • Mark, Thomas;
    • Moses, Alan C.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Differential brain responses to satiation in obese and lean men.

    Published in:
    2000
    By:
    • Gautier, Jean-Francois;
    • Chen, Kewei;
    • Salbe, Arline D.;
    • Bandy, Daniel;
    • Pratley, Richard E.;
    • Heiman, Mark;
    • Ravussin, Eric;
    • Reiman, Eric M.;
    • Tataranni, P. Antonio;
    • Gautier, J F;
    • Chen, K;
    • Salbe, A D;
    • Bandy, D;
    • Pratley, R E;
    • Heiman, M;
    • Ravussin, E;
    • Reiman, E M;
    • Tataranni, P A
    Publication type:
    journal article
    45
    46
    47
    48
    49

    Intestinal Microbiota and Short-Chain Fatty Acids in Association with Advanced Metrics of Glycemia and Adiposity Among Young Adults with Type 1 Diabetes and Overweight or Obesity.

    Published in:
    Current Developments in Nutrition, 2022, v. 6, n. 10, p. 1, doi. 10.1093/cdn/nzac107
    By:
    • Igudesman, Daria;
    • Crandell, Jamie;
    • Corbin, Karen D;
    • Muntis, Franklin;
    • Zaharieva, Dessi P;
    • Casu, Anna;
    • Thomas, Joan M;
    • Bulik, Cynthia M;
    • Carroll, Ian M;
    • Pence, Brian W;
    • Pratley, Richard E;
    • Kosorok, Michael R;
    • Maahs, David M;
    • Mayer-Davis, Elizabeth J
    Publication type:
    Article
    50